AlphaGen
Access AlphaGen
Company Narratives

Chenab Limited Q3 FY2026: Export Sales Shrink, Liquidity Tightens

Chenab’s March 2026 result shows direct export sales collapsing while processing income holds up, gross losses persist, and liquidity pressure intensifies.

Sep 20, 2026

Verdict

Chenab Limited’s March 2026 result shows a business still under severe operating and working-capital pressure. Nine-month sales fell 36.6% to Rs1.189 billion and the gross loss widened to Rs118.9 million, while the after-tax loss increased 6.4% to Rs477.5 million. Q3 gross loss narrowed in absolute terms, but revenue still fell 23.9% and gross margin remained deeply negative. The more revealing shift is in sales mix: direct export product sales collapsed during the nine months, while processing and conversion income was broadly stable. At the same time, current liabilities rose, cash fell and overdue loan installments grew. Lower finance cost and sponsor funding offered relief, but did not repair the core operating deficit.

Company Name: Chenab Limited

Ticker: CHBL

Reporting period: Nine months and third quarter ended March 31, 2026

Reporting basis: Company-level unaudited condensed interim financial statements prepared under the accounting and reporting standards applicable in Pakistan for interim reporting, including IAS 34. The statements are presented in Pakistani rupees. The quarterly package is marked unaudited and does not contain an independent auditor review report.

Alpha QoQ Score: 41.34

TTM Performance Score: 19.97

3Y Business Perf Score: 27.96

Sector Leadership Score: 26.33

These four scores are AlphaGen model outputs, not company-reported figures.

Results at a glance

  • 9MFY26 sales fell 36.6% to Rs1.189 billion from Rs1.875 billion. The gross loss widened 37.1% to Rs118.9 million, taking gross margin to about -10.0% from -4.6%.
  • Nine-month loss before levies and income tax increased 7.8% to Rs459.3 million, while the after-tax loss increased 6.4% to Rs477.5 million. EPS was negative Rs4.15 versus negative Rs3.90.
  • Q3 revenue fell 23.9% to Rs342.1 million. The gross loss narrowed 18.0% to Rs46.9 million, but because sales fell faster, gross margin worsened to about -13.7% from -12.7%.
  • Q3 after-tax loss was Rs161.6 million versus Rs159.4 million a year earlier, broadly flat in absolute terms despite the much smaller revenue base.
  • Nine-month direct export sales of fabrics, made-ups and garments fell 70.8% to Rs292.3 million, while processing and conversion income rose 2.1% to Rs850.6 million. Processing income represented roughly 72% of reported sales versus about 44% a year earlier.
  • The Board recommended no cash dividend, bonus shares, right shares or other entitlement with the March result.
  • Finance cost fell 11.7% over nine months to Rs143.4 million and 6.7% in Q3 to Rs45.1 million.
  • Net operating cash flow fell 78.9% to Rs30.3 million. Operations were cash-negative before working-capital movements, and positive cash generation depended on receivable releases and higher payables.
  • At March 31, current assets were Rs719.8 million against current liabilities of Rs2.771 billion, leaving a working-capital deficit of about Rs2.051 billion. Cash fell to Rs23.4 million.
  • The current portion of long-term financing rose to Rs1.074 billion from Rs627.6 million at June 2025, while overdue installments rose to Rs282.0 million from Rs45.9 million.

What improved

The strongest improvement was the reduction in finance cost. Nine-month finance cost declined to Rs143.4 million from Rs162.4 million, while Q3 finance cost fell to Rs45.1 million from Rs48.3 million. The filing shows lower effective markup ranges on short-term financing than in the prior year, and short-term bank borrowings were down to Rs154.5 million from Rs182.2 million at June 2025. SBP had also reduced the policy rate to 10.5% by March 2026. These factors are consistent with some easing in the financing burden, although Chenab does not quantify how much of the reduction came from lower benchmark rates versus changes in borrowing balances and repayment terms.

The Q3 gross loss narrowed from Rs57.2 million to Rs46.9 million. That is a real improvement in the amount lost before operating expenses, but the sales decline was larger, so gross margin actually deteriorated. Q3 other income rose to Rs11.9 million from Rs8.2 million, mainly because rental income increased. These cushions helped keep the quarterly loss before levies and tax close to the prior-year level despite substantially lower sales.

Working capital generated some cash. Trade debts fell by Rs47.5 million during the nine-month period and loans and advances released another Rs37.3 million. Trade and other payables increased by Rs173.2 million. Together, working-capital movements contributed about Rs260.9 million, allowing Chenab to report positive operating cash flow even though cash flow before working-capital changes was negative Rs186.9 million. This is useful liquidity, but its quality is weaker than cash generated from profitable operations.

What weakened / needs attention

The biggest deterioration is the collapse in revenue scale and the change in mix. Nine-month direct export sales of fabrics, made-ups and garments fell from about Rs1.003 billion to Rs292.3 million, a decline of 70.8%. Local product sales fell 19.5% to Rs55.0 million. Processing and conversion income, by contrast, edged up to Rs850.6 million. Economically, Chenab has shifted toward earning conversion income while direct product sales have shrunk sharply. That may keep machinery and labor engaged, but the filing does not disclose processing volumes, capacity utilization, customer concentration or unit margins, so it is not possible to conclude that the shift improves long-term profitability.

The cost structure remains the central problem. Nine-month sales fell 36.6%, but the company still recorded a Rs118.9 million gross loss, 37.1% larger than a year earlier. Fuel and power expense declined to Rs374.3 million from Rs443.8 million and wages fell to Rs201.3 million from Rs294.6 million, but those reductions were not enough to restore gross profitability. Q3 raw material consumption was actually higher year on year—Rs91.1 million versus Rs46.2 million—even as sales fell. That could reflect product mix, inventory timing or input pricing; the filing does not provide enough volume data to isolate the cause, so attributing it to any one factor would be speculative.

Administrative expense moved the wrong way. It increased 7.1% over nine months to Rs225.4 million and 32.9% in Q3 to Rs71.7 million. Selling and distribution expense fell sharply, consistent with the much smaller direct-export business, but the administrative cost base did not contract with revenue. This leaves Chenab with a heavy fixed-cost burden relative to its current scale.

Other income also became a much smaller earnings support. It fell 71.1% over nine months to Rs40.0 million. The comparable period included Rs114.1 million of balances written back, versus only Rs5.8 million in the current period. This is important for earnings quality: the prior-year result had a sizeable non-operating benefit that did not recur at the same scale. Rental income has increased, but it is not large enough to offset the operating deficit.

Liquidity is the harder issue than the quarterly income statement

Current liabilities increased 26.4% from June 2025 to Rs2.771 billion, while current assets fell 14.6% to Rs719.8 million. The working-capital deficit therefore widened to roughly Rs2.051 billion from Rs1.350 billion. Cash and bank balances fell 58.7% to Rs23.4 million, trade payables increased to Rs1.531 billion, and the current portion of long-term financing jumped 71.1% to Rs1.074 billion.

The loan note is even more revealing. Installments classified as overdue rose to Rs282.0 million from Rs45.9 million at June 2025, while another Rs791.6 million was payable within one year. Long-term financing itself declined as repayments were made, but the amount moving into the near-term bucket rose sharply. Lower long-term principal therefore does not by itself mean lower liquidity risk; the timing of repayments has become more demanding.

Sponsor support is helping bridge that gap. Chenab received Rs134.7 million as a director loan during the nine months, taking directors’ loans to Rs1.207 billion. Management states that sponsors have committed to inject more funds over coming years and that it is seeking additional export-based working capital from banks. Those are potential sources of liquidity, but they are not substitutes for a positive gross margin and internally generated cash.

Chenab reports share capital and reserves of negative Rs895.5 million at March 2026, with accumulated losses of Rs9.120 billion. Directors’ loans are presented within that section of the official balance sheet, so sponsor funding supports the reported capital structure even as accumulated losses continue to rise.

Cash flow: positive, but dependent on creditors and working-capital release

Net cash generated from operations was Rs30.3 million, down from Rs143.3 million a year earlier. Before working-capital changes, operations consumed Rs186.9 million of cash. The positive final number came after a Rs260.9 million working-capital contribution, led by the increase in trade and other payables and reductions in trade debts and advances. This distinction matters because extending supplier balances or collecting receivables can support liquidity for a period, but neither can indefinitely replace cash generation from profitable production.

The Rs134.7 million director loan helped fund Rs155.1 million of long-term financing repayments and a Rs27.7 million reduction in short-term bank borrowings. After Rs15.3 million of investing cash outflow, total cash still fell by Rs33.3 million. Borrowing reduction is therefore occurring alongside sponsor funding and creditor support.

Sector context: Chenab’s contraction was much sharper than the broader textile export picture

Pakistan’s textile backdrop was difficult but mixed, rather than uniformly collapsing. The Pakistan Economic Survey reports that cotton-cloth export value fell 10.9% during July–March FY2026, while cotton-yarn export value increased 4.4%. PBS data for March 2026 show year-on-year declines of 14.5% in knitwear, 6.5% in readymade garments, 6.5% in bed wear and 1.7% in cotton cloth, while cotton-yarn export value rose 8.0%. These figures support a weaker external environment in several value-added categories, but Chenab’s 70.8% nine-month fall in direct export product sales was far more severe than the sector-level decline in cotton cloth. That indicates company-specific scale, customer, financing or operating constraints likely mattered alongside industry conditions; the filing does not disclose enough detail to allocate the decline among those factors.

A broad listed composite peer provides the same caution. Nishat Mills’ unconsolidated Q3 revenue rose about 2.6% year on year to Rs46.4 billion while gross profit remained positive, even though its quarterly profit declined. The businesses differ greatly in size, financial strength and mix, so this is not a direct performance ranking. It simply shows that a negative gross margin and a 24% quarterly sales contraction were not inevitable outcomes for every textile composite company during the period.

Management also pointed to the Middle East conflict as a source of higher input costs, delivery delays and financial instability. SBP’s March 9 monetary-policy statement independently noted that the conflict had sharply increased global fuel, freight and insurance costs and disrupted cross-border trade and travel. That makes the mechanism plausible at an industry level, but Chenab does not quantify the rupee impact on its own quarter, so no specific portion of the gross loss can be assigned to the conflict.

Recurring versus exceptional / non-recurring drivers

  • Recurring pressure: negative gross margin, weak revenue scale, administrative overhead, finance cost and a large working-capital deficit remain embedded in the operating base.
  • Mix shift: processing and conversion income has become the dominant revenue stream while direct export product sales have contracted sharply. Whether that mix can produce sustainable positive gross margin is still unproven.
  • Non-recurring support: prior-year other income included a Rs114.1 million balance write-back; the current period included only Rs5.8 million. This makes year-on-year bottom-line comparisons cleaner when the write-back is separated.
  • Liquidity support rather than earnings: director loans and increases in payables support cash but are financing/working-capital actions, not recurring operating profit.
  • Potential asset monetization: management’s plan to sell non-operational assets is a balance-sheet event, not an earnings driver until transactions are completed.

Post-period development: asset sales moved from plan to Board approval

A material development after the March reporting date strengthens the relevance of asset monetization. On September 9, 2026, Chenab disclosed that its Board had approved, subject to secured-creditor approval, the proposed sale of its weaving-unit land, buildings and plant at Shahkot, another land-and-building unit at Jhumra Road, and open plots outside the main Nishatabad unit. The company described these assets as non-core and said the sale proceeds would be used for debt repayment. No sale price or completed transaction was disclosed in that notice. This development should therefore be treated as a financing and deleveraging pathway, not as realized cash or profit.

The March filing had already said management was negotiating for creditor consent to sell non-operational assets expected to generate up to Rs800 million for upcoming installments. The September Board approval shows execution has advanced, but the key gates remain creditor approval, transaction completion, realized proceeds and actual debt reduction.

What to monitor next

  • Direct export sales: whether product exports recover from the 70.8% nine-month decline or processing income remains the dominant revenue source.
  • Gross margin: whether Chenab can move from a roughly -13.7% Q3 gross margin toward breakeven as sales and utilization change.
  • Overdue debt and the current portion of long-term financing: whether Rs282.0 million of overdue installments and the broader Rs1.074 billion current maturity burden are reduced.
  • Asset disposals: secured-creditor approval, binding sale agreements, realized proceeds and the amount applied to debt.
  • Operating cash before working capital: whether the negative Rs186.9 million pre-working-capital cash result can turn positive without relying on higher payables.
  • Sponsor and bank funding: actual director-loan injections and any additional export-financing limits versus management’s stated plans.
  • Interest rates: SBP’s policy rate stood at 11.5% after the September 14, 2026 meeting, higher than the 10.5% rate at the March reporting date, increasing the financing hurdle for the next cycle even though Chenab’s actual markup depends on its facilities and scheme terms.
  • Revenue mix and utilization: any disclosure of volumes, capacity usage, customer concentration or margins on processing/conversion work.

Bottom line

Chenab’s March 2026 result does not show an operating turnaround. The business generated materially less revenue, remained gross-loss-making and ended the period with a larger working-capital deficit, more debt falling due within one year and much higher overdue installments. The fact that Q3 gross loss narrowed and finance cost fell is helpful, but it does not offset the decline in sales scale or the weakness in liquidity.

The next cycle has two separate tests. The operating test is whether direct exports, utilization and gross margin improve enough for the core textile business to generate cash before working-capital movements. The balance-sheet test is whether sponsor funding and the proposed non-core asset sales translate into actual debt reduction, especially against overdue and near-term obligations. Until both improve together, lower finance cost or temporary working-capital releases should be read as relief rather than evidence of durable earnings normalization.

Sources

Explore more research

All articles